Mefloquine
- TRADE NAMES: Lariam (Roche); Laricam; Mephaquin; Mephaquine
- INDICATIONS: Malaria
- CLASS: Antimalarial, Antimicrobial, Antiprotozoal
- HALF-LIFE: 21–22 days
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Acebutolol, Artemether/Lumefantrine, Ethosuximide, Halofantrine, Ketoconazole, Lacosamide, Moxifloxacin, Oxcarbazepine, Quinine, Tiagabine, Typhoid Vaccine, Vigabatrin
PREGNANCY CATEGORY: C
NEUROPSYCHIATRIC ADVERSE REACTIONS
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
SKIN.
HAIR.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RESPIRATORY.
OTHER.
Page last updated 08/01/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
